Clinical aspects of neuroscience
Organiser and Chair: Pawe³ P. Liberski (Medical University, Lodz) and Andrzej Szczudlik (Jagiellonian University, Collegium Medicum, Krakow) (Room B1)

Session I: Small vessel disease of the brain

1. Hugh Markus (St George's University of London, UK)
   Pathogenesis of lacunar stroke.
2. Christian Enzinger (Medical University Graz, Austria)
   Radiological spectrum of small vessel disease.
3. Hugues Chabriat (CHU Lariboisiere, Assistance Publique des Hopitaux de Paris, Paris, France)
   Single-gene ischemic small vessel diseases of the brain.
4. Agnieszka S³owik (Jagiellonian University, Collegium Medicum, Krakow)
   Genetic risk factors of silent and symptomatic small vessel disease.

Session II: Perspectives of neurodegenerative diseases

1. Cezary Zekanowski (Medical Research Center, Polish Academy of Sciences, Warsaw)
   Inherited mitochondrial DNA variation and Alzheimer’s disease.
2. Mony J. De Leon (New York University School of Medicine, New York, USA)
   MRI biomarkers of dementia.
3. Marcin Sadowski (New York University School of Medicine, New York, USA)
   Therapeutic approach to prion disease: can immunization or drugs be effective?
4. Maria Barcikowska (Medical Research Center, Polish Academy of Sciences, Warsaw)
   Mild cognitive impairment.

Newest Translational Approaches to Clinical and Basic Sciences of Neuromuscular Diseases
Organiser and Chair: Valerie Askanas (University of Southern California, Los Angeles, USA) and S³awomir Wojcik (Medical University of Gdansk) (Room B1)

Session I
Co-Chairs: Lawrence Stern (USA) and Fernando Tome (France)

1. George Karpati (Montreal, Canada)
   Molecular Basis of Muscular Dystrophies.
2. Serge Braun (Paris, France)
   Future of Stem-Cell Therapy for Neuromuscular Diseases.
3. Corrado Angelini (Padova, Italy)
   Molecular Aspects of Metabolic Myopathies and Their Treatments.
4. Anthony H. Schapira (London, UK)
   Pathogenesis and Prospects of Treatment of Mitochondrial Myopathies.

Session II
Chair: Steven P. Ringel (USA)

1. Massimo Zeviani (Milano, Italy)
   Breaking the Magic Circle: from Mitochondria Myopathies to Mitochondrial Medicine.
2. Marinos C. Dalakas (Bethesda, USA/Athens, Greece)
   Immunopathology and Immunomodulatory Therapy of Dermatomyositis and Polymyositis.
3. Valerie Askanas (Los Angeles, USA)
   Molecular Pathogenesis and Prospects of Treatment of Inclusion-Body Myositis.
4. Michel Fardeau (Paris, France)
   Genetic Studies in a Patient with Cap Disease.
5. Anna Nogalska (Los Angeles, USA/Gdansk, Poland)
   Role of Endoplasmic Reticulum Stress in Muscle Diseases.
6. Slawomir Wojcik (Gdansk, Poland)
   Novel Pathogenic Aspects of Myostatin and Therapeutic Potential in Human Neuromuscular Diseases.

Session III
Chair: Barbara Emeryk-Szajewska (Warsaw, Poland)

1. Angela Vincent (London, UK)
   Neuromuscular Junction Biology, Its Disorders and Newest Aspects of Treatment.
2. Stanley Appel (Houston, USA)
   Motor Neuron Biology, Pathology and Treatment of Amyotrophic Lateral Sclerosis.
3. Andrea Martinuzzi (Conegliano, Italy)
   Spastic Paraparesis - Gene Abnormalities and Potential Treatments.
4. Ueli Suter (Zurich, Switzerland)
   Myelin and Axons: Lessons Learned from Inherited Peripheral Neuropathies.
5. W. King Engel (Los Angeles, USA)
   Molecular Pathogenesis and Treatment of Immune-Mediated Neuropthies.

The Progress of Neurological Sciences Improves Clinical Practice
Organiser and Chair: Irena Hausmanowa-Petrusewicz (Medical Research Center, Polish Academy of Sciences, Warsaw)

1. Maria Jêdrzejowska (Medical Research Center, Polish Academy of Sciences, Warsaw)
   Molecular mechanisms modyfying the course of genetic diseases.
2. Arthur Burghes (State University, Ohio, USA)
   SMN and SMA how does it all fit together .
3. Gerta Vrbova (University College, London, UK)
   Spinal muscular atrophy a defect of muscle maturation .
4. Irena Hausmanowa-Petrusewicz (Medical Research Center, Polish Academy of Sciences, Warsaw)
   Spinal muscular atrophy (SMA) - a neurodevelopmental disorder.
5. Agnieszka S³owik (Jagiellonian University, Collegium Medicum, Krakow)
   Paradoxonase gene polymorphism and sporadic ALS.

1. Jolanta Rêdowicz (Nencki Institute of Experimental Biology, Warsaw)
   Non-muscle myosine in disorders of cardiac muscle.
2. Antoni Wrzosek (Nencki Institute of Experimental Biology, Warsaw)
   Molecular mechanism of cardiac muscle contraction control.
3. Anna Fidziañska (Medical Research Center, Polish Academy of Sciences, Warsaw)
   Structure of nucleus and its abnormalities in neuromuscular disorders.
4. Andrzej Kochañski (Medical Research Center, Polish Academy of Sciences, Warsaw)
   Mutation or polymorphism in neurodegenerative disorders?.
5. Jacek Zaremba, Anna Su³ek (Institute of Psychiatry and Neurology, Warsaw)
   Molecular aspects of two myotonic dystrophies.